Related Experiment Videos
Theophylline and airway inflammation
1Krankenhaus Grosshansdorf, Zentrum für Pneumologie und Thoraxchirurgie, LVA Hamburg, Germany.
Summary
Theophylline is emerging as an anti-inflammatory drug for asthma, not just a bronchodilator. Its ability to reduce airway inflammation and suppress late-phase asthmatic reactions suggests a broader therapeutic role.
Area of Science:
- Pharmacology
- Immunology
- Respiratory Medicine
Background:
- Theophylline's role in asthma therapy is traditionally as a second-line bronchodilator.
- Recent research reveals theophylline's significant anti-inflammatory properties in airway inflammation.
Purpose of the Study:
- To review recent advances in understanding theophylline's actions.
- To highlight theophylline's potential as an anti-inflammatory agent in asthma.
Main Methods:
- Review of recent scientific literature on theophylline's mechanisms of action.
- Analysis of in vitro and in vivo studies on immune cell function and asthmatic reactions.
Main Results:
- Theophylline influences the development and maintenance of airway inflammation by altering inflammatory cell function.
- Theophylline suppresses late-phase asthmatic reactions at lower serum concentrations.
- In vitro studies demonstrate theophylline's inhibition of pro-inflammatory immune cell functions.
Conclusions:
- Theophylline exhibits anti-inflammatory effects in asthmatic airways.
- Its actions extend beyond bronchodilation, supporting a role in managing airway inflammation in asthma.